#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Soft tissue necrosis Amyloidosis Epilepsy with myoclonic-atonic seizures Neovascular age-related macular degeneration Aspergillus infection Facioscapulohumeral muscular dystrophy Sjogren's syndrome Anal fistula Short stature homeobox gene mutation Autoimmune hepatitis HER2 mutant non-small cell lung cancer Ataxia telangiectasia Undifferentiated sarcoma Congenital megacolon Henoch-Schonlein purpura nephritis More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Treatment Hereditary neuropathic amyloidosis – Life with Disease Pemphigus Acquired haemophilia – Treatment Bronchiolitis obliterans syndrome – Trials in Disease Factor VIII deficiency – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) Idiopathic pulmonary fibrosis – Life with Disease Glycogen storage disease type V – Treatment Hereditary angioedema – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Db-Oto-3 Voriconazole Testosterone Undecanoate Capsaicin Taxanes Tebipenem Pivoxil Hydrobromide Cobicistat Magnesium Hydroxide Fluoroestradiol F-18 Ecoo16 Litenimod Sodium Omalizumab Tak-280 Rosuvastatin Calcium Piritramide Raludotatug Deruxtecan Hct116-B Desonide Lovastatin Atorvastatin Calcium More therapies…

    Learn about Your Condition

    Syphilis Bladder cancer Juvenile absence epilepsy Alveolar rhabdomyosarcoma Eye inflammation Essential hypertension Craniotomy Spinal cord injury Brain injury Renal failure Oesophagogastroscopy Aortic valve disease Desmoplastic melanoma Femoral neck fracture Persistent depressive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasm

  • A study to evaluate the safety and effectiveness of BMS-986523 alone or in combination with a drug combination for patients with advanced solid tumors and KRAS alterations.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Spain

  • A study to compare using a half dose of iomeprol versus a standard dose of iomeprol for imaging lung tumors with spectral CT scans.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Iomeprol
    Spain

  • A study to investigate the safety and effectiveness of WEF-001 in patients with advanced KRAS-mutant solid tumors

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • WEF-001
    Spain

  • Study of WEF-001 safety and effectiveness in patients with advanced KRAS-mutant solid tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Neoplasm
    Investigated Drugs:
    • WEF-001
    Spain

  • Study of Valemetostat Tosylate with Drug Combination for Patients with Previously Treated Solid Tumors

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Valemetostat Tosilate
    • Datopotamab Deruxtecan
    • Trastuzumab Deruxtecan
    France Italy Spain

  • Study on Pembrolizumab, Atezolizumab, and Nivolumab with Carbon Ion Radiotherapy for Patients with Advanced Melanoma, Urothelial Carcinoma, NSCLC, or Head & Neck Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Atezolizumab
    • Cemiplimab
    • Nivolumab
    Italy
Previous Page
1 … 11 12 13 14 15 … 25
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!